A retrospective comparison of the morbidity and cost of different reconstructive strategies in oral and oropharyngeal carcinoma.
Meeting of the American Society for Head and Neck Surgery. Scottdale, AZ, USA, 1997/05/12.
Evaluate and compare the morbidity and costs of different reconstructive strategies in oral and oropharyngeal carcinoma.
Patients and Methods
One hundred twenty-seven consecutive patients treated surgically for oral and oropharyngeal carcinoma between 1990 and 1996 were evaluated.
Sixty-three patients had segmental mandibulectomies with 30 plate-soft tissue reconstructions and 33 bone-soft tissue flaps.
Sixty-four patients had soft-tissue-only reconstructions.
The following outcome parameters were analyzed
Operative time, intraoperative blood loss, postoperative admission length, ICU and coronary care unit admission length, surgical interventions for complications, re-admissions, and prolonged (>6 mo) gastrostomy tube feeding, and all costs within the disease-free interval.
Means and standard deviations were calculated for continuous parameters.
Differences among the three groups were analyzed using one-way analysis of variance.
For discontinuous parameters, the chi-square test was applied.
Longer operative time (1.8 h) and more blood loss (150 mL) for bone-soft tissue flaps were the only statistically significant findings (P<. 05) between the three groups.
There is no rationale for allowing presumed factors of morbidity or cost select for type of reconstruction in patients with oral and oropharyngeal carcinoma.
Mots-clés Pascal : Carcinome épidermoïde, Cavité buccale, Oropharynx, Reconstruction, Morbidité, Coût, Complication, Rétrospective, Traitement, Economie, Homme, Etude comparative, Stomatologie, Cavité buccale pathologie, Tumeur maligne, ORL pathologie, Pharynx pathologie, Chirurgie plastique
Mots-clés Pascal anglais : Squamous cell carcinoma, Oral cavity, Oropharynx, Reconstruction, Morbidity, Costs, Complication, Retrospective, Treatment, Economy, Human, Comparative study, Stomatology, Oral cavity disease, Malignant tumor, ENT disease, Pharynx disease, Plastic surgery
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0290913
Code Inist : 002B30A04B. Création : 16/11/1999.